Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 07 entities : Eli lilly and company save search
DTx Pharma Appoints Jill Howe as Chief Financial Officer
Published: 2021-06-07 (Crawled : 12:00) - biospace.com/
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: -0.01%
H: 15.52%
C: 10.16%
pharma
AnHeart and Innovent Releases Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting
Published: 2021-06-07 (Crawled : 07:00) - biospace.com/
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: -0.01%
H: 15.52%
C: 10.16%
heart positive results trial
Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting
Published: 2021-06-07 (Crawled : 01:00) - prnewswire.com
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: -0.01%
H: 15.52%
C: 10.16%
heart positive results trial
Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021
Published: 2021-06-07 (Crawled : 01:00) - prnewswire.com
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: -0.01%
H: 15.52%
C: 10.16%
INCY | $51.44 -0.41% 97K
|
Health Technology
|
| O: 0.18%
H: 2.77%
C: 1.95%
chinese solid tumors phase 1 results phase 3 phase 2
Innovent and HUTCHMED Release Phase 1b preliminary Results of TYVYT (Sintilimab Injection) plus Fruquintinib as a Third Line Treatment for Advanced Colorectal Cancer at ASCO Annual Meeting 2021
Published: 2021-06-07 (Crawled : 01:00) - prnewswire.com
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: -0.01%
H: 15.52%
C: 10.16%
treatment phase 1 injection results cancer colorectal cancer phase 1b phase 2b
Innovent Releases the Phase Ia/Ib Dose-Escalation Trial Results of IBI110 (anti-LAG-3) in Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021
Published: 2021-06-07 (Crawled : 01:00) - prnewswire.com
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: -0.01%
H: 15.52%
C: 10.16%
solid tumors results trial trial results
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.78 52.14% 15M
|
SYRA | $1.5 51.23% 1M
|
n/a
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
RILY | $30.325 39.62% 6.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
TROO | $1.41 29.36% 280K
|
Manufacturing
MULN | News | $3.445 26.19% 980K
|
Information
RBBN 4 | $3.21 24.9% 580K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.